{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T21:05:36Z","timestamp":1793999136311,"version":"4.8.0"},"reference-count":226,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T00:00:00Z","timestamp":1705881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T00:00:00Z","timestamp":1705881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1038\/s41584-023-01067-4","type":"journal-article","created":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T05:02:28Z","timestamp":1705899748000},"page":"81-100","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["Engineering approaches for RNA-based and cell-based osteoarthritis therapies"],"prefix":"10.1038","volume":"20","author":[{"given":"Carlisle R.","family":"DeJulius","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie L.","family":"Walton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3591-4246","authenticated-orcid":false,"given":"Juan M.","family":"Colazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"d\u2019Arcy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Francini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Brunger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3979-0620","authenticated-orcid":false,"given":"Craig L.","family":"Duvall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,22]]},"reference":[{"key":"1067_CR1","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1002\/jor.21134","volume":"28","author":"JL Hsieh","year":"2010","unstructured":"Hsieh, J. L. et al. Intraarticular gene transfer of thrombospondin-1 suppresses the disease progression of experimental osteoarthritis. J. Orthop. Res. 28, 1300\u20131306 (2010).","journal-title":"J. Orthop. Res."},{"key":"1067_CR2","doi-asserted-by":"publisher","first-page":"116361","DOI":"10.1016\/j.taap.2022.116361","volume":"459","author":"MA Rabie","year":"2023","unstructured":"Rabie, M. A. et al. Intra-articular injection of rAAV-hFGF-2 ameliorates monosodium iodoacetate-induced osteoarthritis in rats via inhibiting TLR-4 signaling and activating TIMP-1. Toxicol. Appl. Pharmacol. 459, 116361 (2023).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"1067_CR3","doi-asserted-by":"publisher","first-page":"684","DOI":"10.3858\/emm.2010.42.10.067","volume":"42","author":"B Chen","year":"2010","unstructured":"Chen, B., Qin, J., Wang, H., Magdalou, J. & Chen, L. Effects of adenovirus-mediated bFGF, IL-1Ra and IGF-1 gene transfer on human osteoarthritic chondrocytes and osteoarthritis in rabbits. Exp. Mol. Med. 42, 684\u2013695 (2010).","journal-title":"Exp. Mol. Med."},{"key":"1067_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/sj.gt.3301608","volume":"9","author":"DD Frisbie","year":"2002","unstructured":"Frisbie, D. D., Ghivizzani, S. C., Robbins, P. D., Evans, C. H. & McIlwraith, C. W. Treatment of experimental equine osteoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonist gene. Gene Ther. 9, 12\u201320 (2002).","journal-title":"Gene Ther."},{"key":"1067_CR5","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.joca.2022.11.010","volume":"31","author":"S Schrenker","year":"2023","unstructured":"Schrenker, S. et al. In vivo rAAV-mediated human TGF-\u03b2 overexpression reduces perifocal osteoarthritis and improves osteochondral repair in a large animal model at one year. Osteoarthritis Cartilage 31, 467\u2013481 (2023).","journal-title":"Osteoarthritis Cartilage"},{"key":"1067_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202008451","volume":"33","author":"J Maih\u00f6fer","year":"2021","unstructured":"Maih\u00f6fer, J. et al. Hydrogel-guided, rAAV-mediated IGF-I overexpression enables long-term cartilage repair and protection against perifocal osteoarthritis in a large-animal full-thickness chondral defect model at one year in vivo. Adv. Mater. 33, e2008451 (2021).","journal-title":"Adv. Mater."},{"key":"1067_CR7","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1177\/03635465211049414","volume":"49","author":"C Lange","year":"2021","unstructured":"Lange, C. et al. rAAV-mediated sox9 overexpression improves the repair of osteochondral defects in a clinically relevant large animal model over time in vivo and reduces perifocal osteoarthritic changes. Am. J. Sports Med. 49, 3696\u20133707 (2021).","journal-title":"Am. J. Sports Med."},{"key":"1067_CR8","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/s41434-021-00243-z","volume":"28","author":"JM Riyad","year":"2021","unstructured":"Riyad, J. M. & Weber, T. Intracellular trafficking of adeno-associated virus (AAV) vectors: challenges and future directions. Gene Ther. 28, 683\u2013696 (2021).","journal-title":"Gene Ther."},{"key":"1067_CR9","doi-asserted-by":"publisher","first-page":"675897","DOI":"10.3389\/fimmu.2021.675897","volume":"12","author":"BA Hamilton","year":"2021","unstructured":"Hamilton, B. A. & Wright, J. F. Challenges posed by immune responses to AAV vectors: addressing root causes. Front. Immunol. 12, 675897 (2021).","journal-title":"Front. Immunol."},{"key":"1067_CR10","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1097\/BOR.0000000000000761","volume":"33","author":"S Mehta","year":"2021","unstructured":"Mehta, S., He, T. & Bajpayee, A. G. Recent advances in targeted drug delivery for treatment of osteoarthritis. Curr. Opin. Rheumatol. 33, 94\u2013109 (2021).","journal-title":"Curr. Opin. Rheumatol."},{"key":"1067_CR11","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.joca.2013.03.018","volume":"21","author":"T Neogi","year":"2013","unstructured":"Neogi, T. The epidemiology and impact of pain in osteoarthritis. Osteoarthritis Cartilage 21, 1145\u20131153 (2013).","journal-title":"Osteoarthritis Cartilage"},{"key":"1067_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-015-2529-0","volume":"15","author":"R Plotnikoff","year":"2015","unstructured":"Plotnikoff, R. et al. Osteoarthritis prevalence and modifiable factors: a population study. BMC Public. Health 15, 1195 (2015).","journal-title":"BMC Public. Health"},{"key":"1067_CR13","doi-asserted-by":"publisher","first-page":"491","DOI":"10.4085\/1062-6050-51.5.08","volume":"52","author":"AC Thomas","year":"2017","unstructured":"Thomas, A. C., Hubbard-Turner, T., Wikstrom, E. A. & Palmieri-Smith, R. M. Epidemiology of posttraumatic osteoarthritis. J. Athl. Train. 52, 491\u2013496 (2017).","journal-title":"J. Athl. Train."},{"key":"1067_CR14","first-page":"44","volume":"128","author":"RF Loeser","year":"2017","unstructured":"Loeser, R. F. The role of aging in the development of osteoarthritis. Trans. Am. Clin. Climatol. Assoc. 128, 44\u201354 (2017).","journal-title":"Trans. Am. Clin. Climatol. Assoc."},{"key":"1067_CR15","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/nm.4324","volume":"23","author":"OH Jeon","year":"2017","unstructured":"Jeon, O. H. et al. Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment. Nat. Med. 23, 775\u2013781 (2017).","journal-title":"Nat. Med."},{"key":"1067_CR16","doi-asserted-by":"publisher","first-page":"6003","DOI":"10.1016\/j.cell.2021.11.003","volume":"184","author":"CG Boer","year":"2021","unstructured":"Boer, C. G. et al. Deciphering osteoarthritis genetics across 826,690 individuals from 9 populations. Cell 184, 6003\u20136005 (2021).","journal-title":"Cell"},{"key":"1067_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/srep44315","volume":"7","author":"CL Wu","year":"2017","unstructured":"Wu, C. L., Kimmerling, K. A., Little, D. & Guilak, F. Serum and synovial fluid lipidomic profiles predict obesity-associated osteoarthritis, synovitis, and wound repair. Sci. Rep. 7, 44315 (2017).","journal-title":"Sci. Rep."},{"key":"1067_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0060301","volume":"6","author":"J-P Copp\u00e9","year":"2008","unstructured":"Copp\u00e9, J.-P. et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 6, e301 (2008).","journal-title":"PLoS Biol."},{"key":"1067_CR19","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1172\/JCI118475","volume":"97","author":"PG Mitchell","year":"1996","unstructured":"Mitchell, P. G. et al. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J. Clin. Invest. 97, 761\u2013768 (1996).","journal-title":"J. Clin. Invest."},{"key":"1067_CR20","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/nature03369","volume":"434","author":"SS Glasson","year":"2005","unstructured":"Glasson, S. S. et al. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 434, 644\u2013648 (2005).","journal-title":"Nature"},{"key":"1067_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.joca.2006.06.012","volume":"15","author":"CM Thomas","year":"2007","unstructured":"Thomas, C. M., Fuller, C. J., Whittles, C. E. & Sharif, M. Chondrocyte death by apoptosis is associated with cartilage matrix degradation. Osteoarthritis Cartilage 15, 27\u201334 (2007).","journal-title":"Osteoarthritis Cartilage"},{"key":"1067_CR22","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/j.1365-2613.2009.00676.x","volume":"90","author":"N Sofat","year":"2009","unstructured":"Sofat, N. Analysing the role of endogenous matrix molecules in the development of osteoarthritis. Int. J. Exp. Pathol. 90, 463\u2013479 (2009).","journal-title":"Int. J. Exp. Pathol."},{"key":"1067_CR23","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1136\/ard.2009.123166","volume":"69","author":"A Lanas","year":"2010","unstructured":"Lanas, A., Tornero, J. & Zamorano, J. L. Assessment of gastrointestinal and cardiovascular risk in patients with osteoarthritis who require NSAIDs: the LOGICA study. Ann. Rheum. Dis. 69, 1453 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"1067_CR24","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1001\/jama.2017.5283","volume":"317","author":"TE McAlindon","year":"2017","unstructured":"McAlindon, T. E. et al. Effect of intra-articular triamcinolone vs saline on knee cartilage volume and pain in patients with knee osteoarthritis: a randomized clinical trial. JAMA 317, 1967\u20131975 (2017).","journal-title":"JAMA"},{"key":"1067_CR25","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1002\/acr.23204","volume":"69","author":"C Cooper","year":"2017","unstructured":"Cooper, C. et al. Use of intraarticular hyaluronic acid in the management of knee osteoarthritis in clinical practice. Arthritis Care Res. 69, 1287\u20131296 (2017).","journal-title":"Arthritis Care Res."},{"key":"1067_CR26","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00441-019-02996-x","volume":"376","author":"B O\u2019Connell","year":"2019","unstructured":"O\u2019Connell, B., Wragg, N. M. & Wilson, S. L. The use of PRP injections in the management of knee osteoarthritis. Cell Tissue Res. 376, 143\u2013152 (2019).","journal-title":"Cell Tissue Res."},{"key":"1067_CR27","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00441-019-03069-9","volume":"378","author":"M Shariatzadeh","year":"2019","unstructured":"Shariatzadeh, M., Song, J. & Wilson, S. L. The efficacy of different sources of mesenchymal stem cells for the treatment of knee osteoarthritis. Cell Tissue Res. 378, 399\u2013410 (2019).","journal-title":"Cell Tissue Res."},{"key":"1067_CR28","first-page":"37","volume":"9","author":"L Montesi","year":"2016","unstructured":"Montesi, L. et al. Long-term weight loss maintenance for obesity: a multidisciplinary approach. Diabetes, Metab. Syndr. Obes. 9, 37\u201346 (2016).","journal-title":"Diabetes, Metab. Syndr. Obes."},{"key":"1067_CR29","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.1016\/j.pmrj.2012.01.005","volume":"4","author":"HK Vincent","year":"2012","unstructured":"Vincent, H. K., Heywood, K., Connelly, J. & Hurley, R. W. Obesity and weight loss in the treatment and prevention of osteoarthritis. PM R 4, S59\u2013S67 (2012).","journal-title":"PM R"},{"key":"1067_CR30","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1177\/2047487319848105","volume":"27","author":"A Cabassi","year":"2020","unstructured":"Cabassi, A. et al. Non-steroidal anti-inflammatory drug effects on renal and cardiovascular function: from physiology to clinical practice. Eur. J. Prev. Cardiol. 27, 850\u2013867 (2020).","journal-title":"Eur. J. Prev. Cardiol."},{"key":"1067_CR31","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2147\/CEOR.S170119","volume":"11","author":"KL Ong","year":"2019","unstructured":"Ong, K. L., Runa, M., Lau, E. & Altman, R. D. Cost-of-illness of knee osteoarthritis: potential cost savings by not undergoing arthroplasty within the first 2 years. Clinicoecon. Outcomes Res. 11, 245\u2013255 (2019).","journal-title":"Clinicoecon. Outcomes Res."},{"key":"1067_CR32","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/S0140-6736(17)30190-3","volume":"389","author":"BW Schreurs","year":"2017","unstructured":"Schreurs, B. W. & Hannink, G. Total joint arthroplasty in younger patients: heading for trouble? Lancet 389, 1374\u20131375 (2017).","journal-title":"Lancet"},{"key":"1067_CR33","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/d41573-020-00073-5","volume":"19","author":"T Thanh Le","year":"2020","unstructured":"Thanh Le, T. et al. The COVID-19 vaccine development landscape. Nat. Rev. Drug. Discov. 19, 305\u2013306 (2020).","journal-title":"Nat. Rev. Drug. Discov."},{"key":"1067_CR34","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/d41573-023-00050-8","volume":"22","author":"K Kingwell","year":"2023","unstructured":"Kingwell, K. First CRISPR therapy seeks landmark approval. Nat. Rev. Drug Discov. 22, 339\u2013341 (2023).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1067_CR35","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1093\/nar\/gkad067","volume":"51","author":"M Egli","year":"2023","unstructured":"Egli, M. & Manoharan, M. Chemistry, structure and function of approved oligonucleotide therapeutics. Nucleic Acids Res. 51, 2529\u20132573 (2023).","journal-title":"Nucleic Acids Res."},{"key":"1067_CR36","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41573-021-00162-z","volume":"20","author":"ST Crooke","year":"2021","unstructured":"Crooke, S. T., Baker, B. F., Crooke, R. M. & Liang, X.-H. Antisense technology: an overview and prospectus. Nat. Rev. Drug. Discov. 20, 427\u2013453 (2021).","journal-title":"Nat. Rev. Drug. Discov."},{"key":"1067_CR37","doi-asserted-by":"publisher","first-page":"115461","DOI":"10.1016\/j.bone.2020.115461","volume":"138","author":"A Nakamura","year":"2020","unstructured":"Nakamura, A., Ali, S. A. & Kapoor, M. Antisense oligonucleotide-based therapies for the treatment of osteoarthritis: opportunities and roadblocks. Bone 138, 115461 (2020).","journal-title":"Bone"},{"key":"1067_CR38","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1089\/oli.2008.0149","volume":"18","author":"RP Hickerson","year":"2008","unstructured":"Hickerson, R. P. et al. Stability study of unmodified siRNA and relevance to clinical use. Oligonucleotides 18, 345\u2013354 (2008).","journal-title":"Oligonucleotides"},{"key":"1067_CR39","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1208\/s12248-010-9210-4","volume":"12","author":"J Wang","year":"2010","unstructured":"Wang, J., Lu, Z., Wientjes, M. G. & Au, J. L. S. Delivery of siRNA therapeutics: barriers and carriers. AAPS J. 12, 492\u2013503 (2010).","journal-title":"AAPS J."},{"key":"1067_CR40","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1038\/nbt1122","volume":"23","author":"DV Morrissey","year":"2005","unstructured":"Morrissey, D. V. et al. Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat. Biotechnol. 23, 1002\u20131007 (2005).","journal-title":"Nat. Biotechnol."},{"key":"1067_CR41","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3389\/fimmu.2017.00331","volume":"8","author":"Z Meng","year":"2017","unstructured":"Meng, Z. & Lu, M. RNA interference-induced innate immunity, off-target effect, or immune adjuvant? Front. Immunol. 8, 331 (2017).","journal-title":"Front. Immunol."},{"key":"1067_CR42","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41392-020-0207-x","volume":"5","author":"B Hu","year":"2020","unstructured":"Hu, B. et al. Therapeutic siRNA: state of the art. Signal. Transduct. Target. Ther. 5, 101 (2020).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"1067_CR43","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1080\/15476286.2018.1445959","volume":"15","author":"JF Lima","year":"2018","unstructured":"Lima, J. F., Cerqueira, L., Figueiredo, C., Oliveira, C. & Azevedo, N. F. Anti-miRNA oligonucleotides: a comprehensive guide for design. RNA Biol. 15, 338\u2013352 (2018).","journal-title":"RNA Biol."},{"key":"1067_CR44","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.biochi.2019.09.003","volume":"167","author":"J Filippova","year":"2019","unstructured":"Filippova, J., Matveeva, A., Zhuravlev, E. & Stepanov, G. Guide RNA modification as a way to improve CRISPR\/Cas9-based genome-editing systems. Biochimie 167, 49\u201360 (2019).","journal-title":"Biochimie"},{"key":"1067_CR45","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1261\/rna.5103703","volume":"9","author":"Y-L Chiu","year":"2003","unstructured":"Chiu, Y.-L. & Rana, T. M. siRNA function in RNAi: a chemical modification analysis. RNA 9, 1034\u20131048 (2003).","journal-title":"RNA"},{"key":"1067_CR46","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1093\/nar\/19.4.747","volume":"19","author":"J-P Shaw","year":"1991","unstructured":"Shaw, J.-P., Kent, K., Bird, J., Fishback, J. & Froehler, B. Modified deoxyoligonucleotides stable to exonuclease degradation in serum. Nucleic Acids Res. 19, 747\u2013750 (1991).","journal-title":"Nucleic Acids Res."},{"key":"1067_CR47","doi-asserted-by":"publisher","first-page":"4672","DOI":"10.1021\/cr050266u","volume":"107","author":"H Kaur","year":"2007","unstructured":"Kaur, H., Babu, B. R. & Maiti, S. Perspectives on chemistry and therapeutic applications of locked nucleic acid (LNA). Chem. Rev. 107, 4672\u20134697 (2007).","journal-title":"Chem. Rev."},{"key":"1067_CR48","first-page":"583","volume":"90","author":"E Quijano","year":"2017","unstructured":"Quijano, E., Bahal, R., Ricciardi, A., Saltzman, W. M. & Glazer, P. M. Therapeutic peptide nucleic acids: principles, limitations, and opportunities. Yale J. Biol. Med. 90, 583\u2013598 (2017).","journal-title":"Yale J. Biol. Med."},{"key":"1067_CR49","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1038\/s41587-022-01334-x","volume":"40","author":"KM Brown","year":"2022","unstructured":"Brown, K. M. et al. Expanding RNAi therapeutics to extrahepatic tissues with lipophilic conjugates. Nat. Biotechnol. 40, 1500\u20131508 (2022).","journal-title":"Nat. Biotechnol."},{"key":"1067_CR50","doi-asserted-by":"publisher","first-page":"16958","DOI":"10.1021\/ja505986a","volume":"136","author":"JK Nair","year":"2014","unstructured":"Nair, J. K. et al. Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing. J. Am. Chem. Soc. 136, 16958\u201316961 (2014).","journal-title":"J. Am. Chem. Soc."},{"key":"1067_CR51","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1038\/s41587-022-01491-z","volume":"40","author":"E Rohner","year":"2022","unstructured":"Rohner, E., Yang, R., Foo, K. S., Goedel, A. & Chien, K. R. Unlocking the promise of mRNA therapeutics. Nat. Biotechnol. 40, 1586\u20131600 (2022).","journal-title":"Nat. Biotechnol."},{"key":"1067_CR52","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1038\/mt.2008.200","volume":"16","author":"K Karik\u00f3","year":"2008","unstructured":"Karik\u00f3, K. et al. Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Mol. Ther. 16, 1833\u20131840 (2008).","journal-title":"Mol. Ther."},{"key":"1067_CR53","doi-asserted-by":"publisher","first-page":"7295","DOI":"10.1021\/jo2012225","volume":"76","author":"H Peacock","year":"2011","unstructured":"Peacock, H., Kannan, A., Beal, P. A. & Burrows, C. J. Chemical modification of siRNA bases to probe and enhance RNA interference. J. Org. Chem. 76, 7295\u20137300 (2011).","journal-title":"J. Org. Chem."},{"key":"1067_CR54","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1136\/annrheumdis-2020-218469","volume":"80","author":"M-L Ji","year":"2021","unstructured":"Ji, M.-L. et al. Precise targeting of miR-141\/200c cluster in chondrocytes attenuates osteoarthritis development. Ann. Rheum. Dis. 80, 356\u2013366 (2021).","journal-title":"Ann. Rheum. Dis."},{"key":"1067_CR55","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/s41551-021-00780-3","volume":"5","author":"SK Bedingfield","year":"2021","unstructured":"Bedingfield, S. K. et al. Amelioration of post-traumatic osteoarthritis via nanoparticle depots delivering small interfering RNA to damaged cartilage. Nat. Biomed. Eng. 5, 1069\u20131083 (2021).","journal-title":"Nat. Biomed. Eng."},{"key":"1067_CR56","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.nano.2015.01.011","volume":"11","author":"H Cho","year":"2015","unstructured":"Cho, H., Pinkhassik, E., David, V., Stuart, J. M. & Hasty, K. A. Detection of early cartilage damage using targeted nanosomes in a post-traumatic osteoarthritis mouse model. Nanomed. Nanotechnol. Biol. Med. 11, 939\u2013946 (2015).","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"1067_CR57","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmat2116","volume":"7","author":"DA Rothenfluh","year":"2008","unstructured":"Rothenfluh, D. A., Bermudez, H., O\u2019Neil, C. P. & Hubbell, J. A. Biofunctional polymer nanoparticles for intra-articular targeting and retention in cartilage. Nat. Mater. 7, 248\u2013254 (2008).","journal-title":"Nat. Mater."},{"key":"1067_CR58","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ijpharm.2015.12.015","volume":"498","author":"J Pradal","year":"2016","unstructured":"Pradal, J. et al. Effect of particle size on the biodistribution of nano- and microparticles following intra-articular injection in mice. Int. J. Pharm. 498, 119\u2013129 (2016).","journal-title":"Int. J. Pharm."},{"key":"1067_CR59","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3109\/10717544.2013.848495","volume":"21","author":"Z Chen","year":"2014","unstructured":"Chen, Z. et al. Development of nanoparticles-in-microparticles system for improved local retention after intra-articular injection. Drug. Deliv. 21, 342\u2013350 (2014).","journal-title":"Drug. Deliv."},{"key":"1067_CR60","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.biomaterials.2013.09.091","volume":"35","author":"AG Bajpayee","year":"2014","unstructured":"Bajpayee, A. G., Wong, C. R., Bawendi, M. G., Frank, E. H. & Grodzinsky, A. J. Avidin as a model for charge driven transport into cartilage and drug delivery for treating early stage post-traumatic osteoarthritis. Biomaterials 35, 538\u2013549 (2014).","journal-title":"Biomaterials"},{"key":"1067_CR61","doi-asserted-by":"publisher","first-page":"14475","DOI":"10.1021\/acsnano.1c04005","volume":"15","author":"SK Bedingfield","year":"2021","unstructured":"Bedingfield, S. K. et al. Top-down fabricated microplates for prolonged, intra-articular matrix metalloproteinase 13 siRNA nanocarrier delivery to reduce post-traumatic osteoarthritis. ACS Nano 15, 14475\u201314491 (2021).","journal-title":"ACS Nano"},{"key":"1067_CR62","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ejpb.2015.03.017","volume":"93","author":"J Pradal","year":"2015","unstructured":"Pradal, J. et al. Intra-articular bioactivity of a p38 MAPK inhibitor and development of an extended-release system. Eur. J. Pharm. Biopharm. 93, 110\u2013117 (2015).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"1067_CR63","doi-asserted-by":"publisher","first-page":"15804","DOI":"10.1021\/jacs.9b06218","volume":"141","author":"Z Tan","year":"2019","unstructured":"Tan, Z. et al. Polycation architecture and assembly direct successful gene delivery: micelleplexes outperform polyplexes via optimal DNA packaging. J. Am. Chem. Soc. 141, 15804\u201315817 (2019).","journal-title":"J. Am. Chem. Soc."},{"key":"1067_CR64","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.biomaterials.2017.01.008","volume":"122","author":"Q Wang","year":"2017","unstructured":"Wang, Q. et al. Targeting NF-kB signaling with polymeric hybrid micelles that co-deliver siRNA and dexamethasone for arthritis therapy. Biomaterials 122, 10\u201322 (2017).","journal-title":"Biomaterials"},{"key":"1067_CR65","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1039\/D2SM01698B","volume":"19","author":"BM Johnston","year":"2023","unstructured":"Johnston, B. M., Grodzinsky, A. J. & Hammond, P. T. Charge shielding effects of PEG bound to NH2-terminated PAMAM dendrimers \u2014 an experimental approach. Soft Matter 19, 3033\u20133046 (2023).","journal-title":"Soft Matter"},{"key":"1067_CR66","doi-asserted-by":"publisher","first-page":"16412","DOI":"10.1021\/acsnano.2c12261","volume":"17","author":"RB Fletcher","year":"2023","unstructured":"Fletcher, R. B. et al. Nonviral in vivo delivery of CRISPR-Cas9 using protein-agnostic, high-loading porous silicon and polymer nanoparticles. ACS Nano 17, 16412\u201316431 (2023).","journal-title":"ACS Nano"},{"key":"1067_CR67","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jconrel.2015.08.025","volume":"216","author":"MJ Kim","year":"2015","unstructured":"Kim, M. J. et al. Notch1 targeting siRNA delivery nanoparticles for rheumatoid arthritis therapy. J. Control. Release 216, 140\u2013148 (2015).","journal-title":"J. Control. Release"},{"key":"1067_CR68","first-page":"BCBCR","volume":"6","author":"H Jin","year":"2012","unstructured":"Jin, H. et al. Delivery of microRNA-10b with polylysine nanoparticles for inhibition of breast cancer cell wound healing. Breast Cancer 6, BCBCR\u2013S8513 (2012).","journal-title":"Breast Cancer"},{"key":"1067_CR69","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jconrel.2018.12.041","volume":"295","author":"AM Ledo","year":"2019","unstructured":"Ledo, A. M. et al. Co-delivery of RNAi and chemokine by polyarginine nanocapsules enables the modulation of myeloid-derived suppressor cells. J. Control. Release 295, 60\u201373 (2019).","journal-title":"J. Control. Release"},{"key":"1067_CR70","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00232-016-9940-z","volume":"250","author":"L Zou","year":"2017","unstructured":"Zou, L., Peng, Q., Wang, P. & Zhou, B. Progress in research and application of HIV-1 TAT-derived cell-penetrating peptide. J. Membr. Biol. 250, 115\u2013122 (2017).","journal-title":"J. Membr. Biol."},{"key":"1067_CR71","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/978-1-0716-1617-8_21","volume":"2355","author":"B Lou","year":"2021","unstructured":"Lou, B., Lau, C. Y. J., Hennink, W. E. & Mastrobattista, E. Preparation of mRNA polyplexes with post-conjugated endosome-disruptive peptides. Methods Mol. Biol. 2355, 275\u2013286 (2021).","journal-title":"Methods Mol. Biol."},{"key":"1067_CR72","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.addr.2016.08.004","volume":"110-111","author":"W Tai","year":"2017","unstructured":"Tai, W. & Gao, X. Functional peptides for siRNA delivery. Adv. Drug. Deliv. Rev. 110-111, 157\u2013168 (2017).","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"1067_CR73","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1016\/j.biomaterials.2013.01.037","volume":"34","author":"KK Hou","year":"2013","unstructured":"Hou, K. K., Pan, H., Lanza, G. M. & Wickline, S. A. Melittin derived peptides for nanoparticle based siRNA transfection. Biomaterials 34, 3110\u20133119 (2013).","journal-title":"Biomaterials"},{"key":"1067_CR74","doi-asserted-by":"publisher","first-page":"E6199","DOI":"10.1073\/pnas.1608245113","volume":"113","author":"H Yan","year":"2016","unstructured":"Yan, H. et al. Suppression of NF-\u03baB activity via nanoparticle-based siRNA delivery alters early cartilage responses to injury. Proc. Natl Acad. Sci. USA 113, E6199\u2013E6208 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1067_CR75","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1002\/art.41794","volume":"73","author":"X Duan","year":"2021","unstructured":"Duan, X. et al. Amelioration of posttraumatic osteoarthritis in mice using intraarticular silencing of periostin via nanoparticle-based small interfering RNA. Arthritis Rheumatol. 73, 2249\u20132260 (2021).","journal-title":"Arthritis Rheumatol."},{"key":"1067_CR76","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41368-022-00190-4","volume":"14","author":"Y Jin","year":"2022","unstructured":"Jin, Y. et al. Histone demethylase JMJD3 downregulation protects against aberrant force-induced osteoarthritis through epigenetic control of NR4A1. Int. J. Oral. Sci. 14, 34 (2022).","journal-title":"Int. J. Oral. Sci."},{"key":"1067_CR77","doi-asserted-by":"publisher","first-page":"6324","DOI":"10.1016\/j.biomaterials.2011.05.017","volume":"32","author":"Y Pi","year":"2011","unstructured":"Pi, Y. et al. Targeted delivery of non-viral vectors to cartilage in vivo using a chondrocyte-homing peptide identified by phage display. Biomaterials 32, 6324\u20136332 (2011).","journal-title":"Biomaterials"},{"key":"1067_CR78","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1021\/bm501394m","volume":"16","author":"H Li","year":"2015","unstructured":"Li, H. et al. Dual MMP7-proximity-activated and folate receptor-targeted nanoparticles for siRNA delivery. Biomacromolecules 16, 192\u2013201 (2015).","journal-title":"Biomacromolecules"},{"key":"1067_CR79","doi-asserted-by":"publisher","first-page":"3040","DOI":"10.1002\/adfm.201202215","volume":"23","author":"H Li","year":"2013","unstructured":"Li, H. et al. Matrix metalloproteinase responsive, proximity-activated polymeric nanoparticles for siRNA delivery. Adv. Funct. Mater. 23, 3040\u20133052 (2013).","journal-title":"Adv. Funct. Mater."},{"key":"1067_CR80","doi-asserted-by":"publisher","first-page":"36938","DOI":"10.1021\/acsami.0c10458","volume":"12","author":"Y Liang","year":"2020","unstructured":"Liang, Y. et al. Chondrocyte-targeted microRNA delivery by engineered exosomes toward a cell-free osteoarthritis therapy. ACS Appl. Mater. Interfaces 12, 36938\u201336947 (2020).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"1067_CR81","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/274923a0","volume":"274","author":"GJ Dimitriadis","year":"1978","unstructured":"Dimitriadis, G. J. Translation of rabbit globin mRNA introduced by liposomes into mouse lymphocytes. Nature 274, 923\u2013924 (1978).","journal-title":"Nature"},{"key":"1067_CR82","doi-asserted-by":"publisher","first-page":"7413","DOI":"10.1073\/pnas.84.21.7413","volume":"84","author":"PL Felgner","year":"1987","unstructured":"Felgner, P. L. et al. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl Acad. Sci. USA 84, 7413\u20137417 (1987).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1067_CR83","doi-asserted-by":"publisher","first-page":"12181","DOI":"10.1021\/acs.chemrev.1c00244","volume":"121","author":"YB Zhang","year":"2021","unstructured":"Zhang, Y. B., Sun, C. Z., Wang, C., Jankovic, K. E. & Dong, Y. Z. Lipids and lipid derivatives for RNA delivery. Chem. Rev. 121, 12181\u201312277 (2021).","journal-title":"Chem. Rev."},{"key":"1067_CR84","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1080\/10717544.2019.1660434","volume":"26","author":"L Kou","year":"2019","unstructured":"Kou, L. et al. Biomaterial-engineered intra-articular drug delivery systems for osteoarthritis therapy. Drug. Deliv. 26, 870\u2013885 (2019).","journal-title":"Drug. Deliv."},{"key":"1067_CR85","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1716153","volume":"379","author":"D Adams","year":"2018","unstructured":"Adams, D. et al. Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N. Engl. J. Med. 379, 11\u201321 (2018).","journal-title":"N. Engl. J. Med."},{"key":"1067_CR86","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s40265-018-0983-6","volume":"78","author":"SM Hoy","year":"2018","unstructured":"Hoy, S. M. Patisiran: first global approval. Drugs 78, 1625\u20131631 (2018).","journal-title":"Drugs"},{"key":"1067_CR87","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202300897","volume":"10","author":"B Dai","year":"2023","unstructured":"Dai, B. et al. Blockage of osteopontin-integrin beta3 signaling in infrapatellar fat pad attenuates osteoarthritis in mice. Adv. Sci. 10, e2300897 (2023).","journal-title":"Adv. Sci."},{"key":"1067_CR88","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/gt.2015.16","volume":"22","author":"Y Pi","year":"2015","unstructured":"Pi, Y. et al. Intra-articular delivery of anti-Hif-2\u0251 siRNA by chondrocyte-homing nanoparticles to prevent cartilage degeneration in arthritic mice. Gene Ther. 22, 439\u2013448 (2015).","journal-title":"Gene Ther."},{"key":"1067_CR89","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00109-018-1705-y","volume":"97","author":"Y Gong","year":"2019","unstructured":"Gong, Y. et al. Inhibition of YAP with siRNA prevents cartilage degradation and ameliorates osteoarthritis development. J. Mol. Med. 97, 103\u2013114 (2019).","journal-title":"J. Mol. Med."},{"key":"1067_CR90","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.omtn.2022.12.008","volume":"31","author":"L Lin","year":"2023","unstructured":"Lin, L., Zhu, S., Huang, H., Wu, L. P. & Huang, J. Chemically modified small interfering RNA targeting Hedgehog signaling pathway for rheumatoid arthritis therapy. Mol. Ther. Nucleic Acids 31, 88\u2013104 (2023).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"1067_CR91","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00441-016-2563-y","volume":"368","author":"H Hoshi","year":"2017","unstructured":"Hoshi, H. et al. Effect of inhibiting MMP13 and ADAMTS5 by intra-articular injection of small interfering RNA in a surgically induced osteoarthritis model of mice. Cell Tissue Res. 368, 379\u2013387 (2017).","journal-title":"Cell Tissue Res."},{"key":"1067_CR92","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1002\/jor.22654","volume":"32","author":"R Akagi","year":"2014","unstructured":"Akagi, R. et al. Effective knock down of matrix metalloproteinase-13 by an intra-articular injection of small interfering RNA (siRNA) in a murine surgically-induced osteoarthritis model. J. Orthop. Res. 32, 1175\u20131180 (2014).","journal-title":"J. Orthop. Res."},{"key":"1067_CR93","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/03008207.2018.1539082","volume":"60","author":"R Nakagawa","year":"2019","unstructured":"Nakagawa, R. et al. Single vs. repeated matrix metalloproteinase-13 knockdown with intra-articular short interfering RNA administration in a murine osteoarthritis model. Connect. Tissue Res. 60, 335\u2013343 (2019).","journal-title":"Connect. Tissue Res."},{"key":"1067_CR94","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1080\/17425255.2019.1691997","volume":"15","author":"WM Oo","year":"2019","unstructured":"Oo, W. M., Liu, X. & Hunter, D. J. Pharmacodynamics, efficacy, safety and administration of intra-articular therapies for knee osteoarthritis. Expert. Opin. Drug. Metab. Toxicol. 15, 1021\u20131032 (2019).","journal-title":"Expert. Opin. Drug. Metab. Toxicol."},{"key":"1067_CR95","doi-asserted-by":"publisher","unstructured":"Hoogenboezem, E. N. et al. Structural optimization of siRNA conjugates for albumin binding achieves effective MCL1-targeted cancer therapy. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2023.02.14.528574 (2023).","DOI":"10.1101\/2023.02.14.528574"},{"key":"1067_CR96","doi-asserted-by":"publisher","first-page":"E6490","DOI":"10.1073\/pnas.1621240114","volume":"114","author":"SM Sarett","year":"2017","unstructured":"Sarett, S. M. et al. Lipophilic siRNA targets albumin in situ and promotes bioavailability, tumor penetration, and carrier-free gene silencing. Proc. Natl Acad. Sci. USA 114, E6490\u2013E6497 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1067_CR97","doi-asserted-by":"publisher","unstructured":"Colazo, J. M. et al. Albumin-binding RNAi conjugate for carrier free treatment of arthritis. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2023.05.31.542971 (2023).","DOI":"10.1101\/2023.05.31.542971"},{"key":"1067_CR98","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3389\/fendo.2018.00402","volume":"9","author":"J O\u2019Brien","year":"2018","unstructured":"O\u2019Brien, J., Hayder, H., Zayed, Y. & Peng, C. Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front. Endocrinol. 9, 402 (2018).","journal-title":"Front. Endocrinol."},{"key":"1067_CR99","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.tig.2022.02.006","volume":"38","author":"C Diener","year":"2022","unstructured":"Diener, C., Keller, A. & Meese, E. Emerging concepts of miRNA therapeutics: from cells to clinic. Trends Genet. 38, 613\u2013626 (2022).","journal-title":"Trends Genet."},{"key":"1067_CR100","doi-asserted-by":"publisher","first-page":"eabk0011","DOI":"10.1126\/sciadv.abk0011","volume":"8","author":"J Zhu","year":"2022","unstructured":"Zhu, J. et al. Stem cell-homing hydrogel-based miR-29b-5p delivery promotes cartilage regeneration by suppressing senescence in an osteoarthritis rat model. Sci. Adv. 8, eabk0011 (2022).","journal-title":"Sci. Adv."},{"key":"1067_CR101","doi-asserted-by":"publisher","first-page":"239","DOI":"10.4172\/2167-7921.1000239","volume":"6","author":"M Zhang","year":"2017","unstructured":"Zhang, M., Lygrisse, K. & Wang, J. Role of MicroRNA in osteoarthritis. J. Arthritis 6, 239 (2017).","journal-title":"J. Arthritis"},{"key":"1067_CR102","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.omtn.2018.09.015","volume":"13","author":"D Baek","year":"2018","unstructured":"Baek, D. et al. Inhibition of miR-449a promotes cartilage regeneration and prevents progression of osteoarthritis in in vivo rat models. Mol. Ther. Nucleic Acids 13, 322\u2013333 (2018).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"1067_CR103","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jconrel.2019.07.040","volume":"309","author":"A Lolli","year":"2019","unstructured":"Lolli, A. et al. Hydrogel-based delivery of antimiR-221 enhances cartilage regeneration by endogenous cells. J. Control. Release 309, 220\u2013230 (2019).","journal-title":"J. Control. Release"},{"key":"1067_CR104","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1002\/jor.23552","volume":"35","author":"BA Anderson","year":"2017","unstructured":"Anderson, B. A. & McAlinden, A. miR\u2010483 targets SMAD4 to suppress chondrogenic differentiation of human mesenchymal stem cells. J. Orthop. Res. 35, 2369\u20132377 (2017).","journal-title":"J. Orthop. Res."},{"key":"1067_CR105","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1136\/annrheumdis-2018-213629","volume":"78","author":"A Nakamura","year":"2019","unstructured":"Nakamura, A. et al. microRNA-181a-5p antisense oligonucleotides attenuate osteoarthritis in facet and knee joints. Ann. Rheum. Dis. 78, 111\u2013121 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"1067_CR106","doi-asserted-by":"publisher","first-page":"8479","DOI":"10.7150\/thno.46761","volume":"10","author":"L Zhang","year":"2020","unstructured":"Zhang, L. et al. Yeast cell wall particle mediated nanotube-RNA delivery system loaded with miR365 antagomir for post-traumatic osteoarthritis therapy via oral route. Theranostics 10, 8479 (2020).","journal-title":"Theranostics"},{"key":"1067_CR107","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.ejpb.2008.09.016","volume":"71","author":"A Yamamoto","year":"2009","unstructured":"Yamamoto, A., Kormann, M., Rosenecker, J. & Rudolph, C. Current prospects for mRNA gene delivery. Eur. J. Pharm. Biopharm. 71, 484\u2013489 (2009).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"1067_CR108","doi-asserted-by":"publisher","DOI":"10.1038\/srep18743","volume":"6","author":"H Aini","year":"2016","unstructured":"Aini, H. et al. Messenger RNA delivery of a cartilage-anabolic transcription factor as a disease-modifying strategy for osteoarthritis treatment. Sci. Rep. 6, 18743 (2016).","journal-title":"Sci. Rep."},{"key":"1067_CR109","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3390\/pharmaceutics12010073","volume":"12","author":"H Yan","year":"2020","unstructured":"Yan, H. et al. Induction of WNT16 via peptide-mRNA nanoparticle-based delivery maintains cartilage homeostasis. Pharmaceutics 12, 73 (2020).","journal-title":"Pharmaceutics"},{"key":"1067_CR110","doi-asserted-by":"crossref","unstructured":"Deng, J. et al. Anti-Inflammatory therapy for temporomandibular joint osteoarthritis using mRNA medicine encoding interleukin-1 receptor antagonist. Pharmaceutics 14 (2022).","DOI":"10.3390\/pharmaceutics14091785"},{"key":"1067_CR111","doi-asserted-by":"publisher","first-page":"839","DOI":"10.3390\/biom10060839","volume":"10","author":"BH Yip","year":"2020","unstructured":"Yip, B. H. Recent advances in CRISPR\/Cas9 delivery strategies. Biomolecules 10, 839 (2020).","journal-title":"Biomolecules"},{"key":"1067_CR112","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1225829","volume":"337","author":"M Jinek","year":"2012","unstructured":"Jinek, M. et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337, 816\u2013821 (2012).","journal-title":"Science"},{"key":"1067_CR113","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1231143","volume":"339","author":"L Cong","year":"2013","unstructured":"Cong, L. et al. Multiplex genome engineering using CRISPR\/Cas systems. Science 339, 819\u2013823 (2013).","journal-title":"Science"},{"key":"1067_CR114","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nbt.2647","volume":"31","author":"PD Hsu","year":"2013","unstructured":"Hsu, P. D. et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat. Biotechnol. 31, 827\u2013832 (2013).","journal-title":"Nat. Biotechnol."},{"key":"1067_CR115","first-page":"2836","volume":"63","author":"MC Jaskolka","year":"2022","unstructured":"Jaskolka, M. C. et al. Exploratory safety profile of EDIT-101, a first-in-human in vivo CRISPR gene editing therapy for CEP290-related retinal degeneration. Investig. Ophthalmol. Vis. Sci. 63, 2836\u2013A0352 (2022).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"1067_CR116","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1056\/NEJMoa2107454","volume":"385","author":"JD Gillmore","year":"2021","unstructured":"Gillmore, J. D. et al. CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis. N. Engl. J. Med. 385, 493\u2013502 (2021).","journal-title":"N. Engl. J. Med."},{"key":"1067_CR117","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1182\/blood-2020-139575","volume":"136","author":"H Frangoul","year":"2020","unstructured":"Frangoul, H. et al. Safety and efficacy of CTX001 in patients with transfusion-dependent \u03b2-thalassemia and sickle cell disease: early results from the climb THAL-111 and climb SCD-121 studies of autologous CRISPR-CAS9-modified CD34+ hematopoietic stem and progenitor cells. Blood 136, 3\u20134 (2020).","journal-title":"Blood"},{"key":"1067_CR118","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01559-z","volume":"21","author":"A Dimitri","year":"2022","unstructured":"Dimitri, A., Herbst, F. & Fraietta, J. A. Engineering the next-generation of CAR T-cells with CRISPR-Cas9 gene editing. Mol. Cancer 21, 78 (2022).","journal-title":"Mol. Cancer"},{"key":"1067_CR119","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/d41586-023-03590-6","volume":"623","author":"C Wong","year":"2023","unstructured":"Wong, C. UK first to approve CRISPR treatment for diseases: what you need to know. Nature 623, 676\u2013677 (2023).","journal-title":"Nature"},{"key":"1067_CR120","doi-asserted-by":"publisher","unstructured":"Sheridan, C. The world\u2019s first CRISPR therapy is approved: who will receive it? Nat. Biotechnol. https:\/\/doi.org\/10.1038\/d41587-023-00016-6 (2023).","DOI":"10.1038\/d41587-023-00016-6"},{"key":"1067_CR121","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.3390\/cells9071608","volume":"9","author":"M Naeem","year":"2020","unstructured":"Naeem, M., Majeed, S., Hoque, M. Z. & Ahmad, I. Latest developed strategies to minimize the off-target effects in CRISPR-Cas-mediated genome editing. Cells 9, 1608 (2020).","journal-title":"Cells"},{"key":"1067_CR122","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00109-020-01893-z","volume":"98","author":"HA Han","year":"2020","unstructured":"Han, H. A., Pang, J. K. S. & Soh, B.-S. Mitigating off-target effects in CRISPR\/Cas9-mediated in vivo gene editing. J. Mol. Med. 98, 615\u2013632 (2020).","journal-title":"J. Mol. Med."},{"key":"1067_CR123","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28244-5","volume":"13","author":"I H\u00f6ijer","year":"2022","unstructured":"H\u00f6ijer, I. et al. CRISPR-Cas9 induces large structural variants at on-target and off-target sites in vivo that segregate across generations. Nat. Commun. 13, 627 (2022).","journal-title":"Nat. Commun."},{"key":"1067_CR124","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.xphs.2019.10.003","volume":"109","author":"A Mehta","year":"2020","unstructured":"Mehta, A. & Merkel, O. M. Immunogenicity of Cas9 protein. J. Pharm. Sci. 109, 62\u201367 (2020).","journal-title":"J. Pharm. Sci."},{"key":"1067_CR125","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1080\/10717544.2018.1474964","volume":"25","author":"CA Lino","year":"2018","unstructured":"Lino, C. A., Harper, J. C., Carney, J. P. & Timlin, J. A. Delivering CRISPR: a review of the challenges and approaches. Drug. Deliv. 25, 1234\u20131257 (2018).","journal-title":"Drug. Deliv."},{"key":"1067_CR126","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41591-019-0344-3","volume":"25","author":"CE Nelson","year":"2019","unstructured":"Nelson, C. E. et al. Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy. Nat. Med. 25, 427\u2013432 (2019).","journal-title":"Nat. Med."},{"key":"1067_CR127","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41586-020-1978-5","volume":"578","author":"JA Doudna","year":"2020","unstructured":"Doudna, J. A. The promise and challenge of therapeutic genome editing. Nature 578, 229\u2013236 (2020).","journal-title":"Nature"},{"key":"1067_CR128","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nbt.3081","volume":"33","author":"JA Zuris","year":"2015","unstructured":"Zuris, J. A. et al. Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo. Nat. Biotechnol. 33, 73\u201380 (2015).","journal-title":"Nat. Biotechnol."},{"key":"1067_CR129","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1016\/j.celrep.2018.02.014","volume":"22","author":"JD Finn","year":"2018","unstructured":"Finn, J. D. et al. A single administration of CRISPR\/Cas9 lipid nanoparticles achieves robust and persistent in vivo genome editing. Cell Rep. 22, 2227\u20132235 (2018).","journal-title":"Cell Rep."},{"key":"1067_CR130","doi-asserted-by":"publisher","first-page":"2868","DOI":"10.1073\/pnas.1520244113","volume":"113","author":"M Wang","year":"2016","unstructured":"Wang, M. et al. Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles. Proc. Natl Acad. Sci. USA 113, 2868\u20132873 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1067_CR131","doi-asserted-by":"publisher","DOI":"10.1002\/marc.201800068","volume":"40","author":"Z Zhang","year":"2019","unstructured":"Zhang, Z. et al. Cationic polymer-mediated CRISPR\/Cas9 plasmid delivery for genome editing. Macromol. Rapid Commun. 40, e1800068 (2019).","journal-title":"Macromol. Rapid Commun."},{"key":"1067_CR132","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06522-5","volume":"9","author":"C Xu","year":"2018","unstructured":"Xu, C. et al. Targeting of NLRP3 inflammasome with gene editing for the amelioration of inflammatory diseases. Nat. Commun. 9, 4092 (2018).","journal-title":"Nat. Commun."},{"key":"1067_CR133","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/s41551-017-0137-2","volume":"1","author":"K Lee","year":"2017","unstructured":"Lee, K. et al. Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA. Nat. Biomed. Eng. 1, 889\u2013901 (2017).","journal-title":"Nat. Biomed. Eng."},{"key":"1067_CR134","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1021\/acsnano.6b07600","volume":"11","author":"R Mout","year":"2017","unstructured":"Mout, R. et al. Direct cytosolic delivery of CRISPR\/Cas9-ribonucleoprotein for efficient gene editing. ACS Nano 11, 2452\u20132458 (2017).","journal-title":"ACS Nano"},{"key":"1067_CR135","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1021\/acs.accounts.9b00106","volume":"52","author":"D Wilbie","year":"2019","unstructured":"Wilbie, D., Walther, J. & Mastrobattista, E. Delivery aspects of CRISPR\/Cas for in vivo genome editing. Acc. Chem. Res. 52, 1555\u20131564 (2019).","journal-title":"Acc. Chem. Res."},{"key":"1067_CR136","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.joca.2018.09.001","volume":"27","author":"CI Seidl","year":"2019","unstructured":"Seidl, C. I., Fulga, T. A. & Murphy, C. L. CRISPR-Cas9 targeting of MMP13 in human chondrocytes leads to significantly reduced levels of the metalloproteinase and enhanced type II collagen accumulation. Osteoarthritis Cartilage 27, 140\u2013147 (2019).","journal-title":"Osteoarthritis Cartilage"},{"key":"1067_CR137","doi-asserted-by":"publisher","first-page":"4866","DOI":"10.7150\/thno.69368","volume":"12","author":"Y Liang","year":"2022","unstructured":"Liang, Y. et al. Chondrocyte-specific genomic editing enabled by hybrid exosomes for osteoarthritis treatment. Theranostics 12, 4866\u20134878 (2022).","journal-title":"Theranostics"},{"key":"1067_CR138","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s00402-019-03140-8","volume":"139","author":"SH Kim","year":"2019","unstructured":"Kim, S. H. et al. Intra-articular injection of mesenchymal stem cells for clinical outcomes and cartilage repair in osteoarthritis of the knee: a meta-analysis of randomized controlled trials. Arch. Orthop. Trauma Surg. 139, 971\u2013980 (2019).","journal-title":"Arch. Orthop. Trauma Surg."},{"key":"1067_CR139","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s40883-020-00184-w","volume":"7","author":"S Shah","year":"2021","unstructured":"Shah, S., Otsuka, T., Bhattacharjee, M. & Laurencin, C. T. Minimally invasive cellular therapies for osteoarthritis treatment. Regen. Eng. Transl. Med. 7, 76\u201390 (2021).","journal-title":"Regen. Eng. Transl. Med."},{"key":"1067_CR140","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/jgm.1334","volume":"11","author":"JD Kay","year":"2009","unstructured":"Kay, J. D. et al. Intra-articular gene delivery and expression of interleukin-1Ra mediated by self-complementary adeno-associated virus. J. Gene Med. 11, 605\u2013614 (2009).","journal-title":"J. Gene Med."},{"key":"1067_CR141","doi-asserted-by":"publisher","first-page":"E798","DOI":"10.1073\/pnas.1321744111","volume":"111","author":"JM Brunger","year":"2014","unstructured":"Brunger, J. M. et al. Scaffold-mediated lentiviral transduction for functional tissue engineering of cartilage. Proc. Natl Acad. Sci. USA 111, E798\u2013E806 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1067_CR142","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1038\/sj.gt.3302515","volume":"12","author":"H Madry","year":"2005","unstructured":"Madry, H. et al. Enhanced repair of articular cartilage defects in vivo by transplanted chondrocytes overexpressing insulin-like growth factor I (IGF-I). Gene Ther. 12, 1171\u20131179 (2005).","journal-title":"Gene Ther."},{"key":"1067_CR143","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.biomaterials.2016.07.017","volume":"104","author":"S Raisin","year":"2016","unstructured":"Raisin, S., Belamie, E. & Morille, M. Non-viral gene activated matrices for mesenchymal stem cells based tissue engineering of bone and cartilage. Biomaterials 104, 223\u2013237 (2016).","journal-title":"Biomaterials"},{"key":"1067_CR144","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201901827","volume":"9","author":"RM Raftery","year":"2020","unstructured":"Raftery, R. M., Gonzalez Vazquez, A. G., Chen, G. & O\u2019Brien, F. J. Activation of the SOX-5, SOX-6, and SOX-9 trio of transcription factors using a gene-activated scaffold stimulates mesenchymal stromal cell chondrogenesis and inhibits endochondral ossification. Adv. Healthc. Mater. 9, e1901827 (2020).","journal-title":"Adv. Healthc. Mater."},{"key":"1067_CR145","doi-asserted-by":"publisher","first-page":"618399","DOI":"10.3389\/fbioe.2020.618399","volume":"8","author":"I Uzieliene","year":"2020","unstructured":"Uzieliene, I., Kalvaityte, U., Bernotiene, E. & Mobasheri, A. Non-viral gene therapy for osteoarthritis. Front. Bioeng. Biotechnol. 8, 618399 (2020).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"1067_CR146","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1002\/jor.24304","volume":"37","author":"F Guilak","year":"2019","unstructured":"Guilak, F. et al. Designer stem cells: genome engineering and the next generation of cell-based therapies. J. Orthop. Res. 37, 1287\u20131293 (2019).","journal-title":"J. Orthop. Res."},{"key":"1067_CR147","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1126\/science.1083653","volume":"300","author":"T Pawson","year":"2003","unstructured":"Pawson, T. & Nash, P. Assembly of cell regulatory systems through protein interaction domains. Science 300, 445\u2013452 (2003).","journal-title":"Science"},{"key":"1067_CR148","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1146\/annurev.biochem.75.103004.142710","volume":"75","author":"RP Bhattacharyya","year":"2006","unstructured":"Bhattacharyya, R. P., Rem\u00e9nyi, A., Yeh, B. J. & Lim, W. A. Domains, motifs, and scaffolds: the role of modular interactions in the evolution and wiring of cell signaling circuits. Annu. Rev. Biochem. 75, 655\u2013680 (2006).","journal-title":"Annu. Rev. Biochem."},{"key":"1067_CR149","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41589-021-00926-z","volume":"18","author":"J Manhas","year":"2022","unstructured":"Manhas, J., Edelstein, H. I., Leonard, J. N. & Morsut, L. The evolution of synthetic receptor systems. Nat. Chem. Biol. 18, 244\u2013255 (2022).","journal-title":"Nat. Chem. Biol."},{"key":"1067_CR150","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1126\/science.abb8205","volume":"370","author":"KS Stapornwongkul","year":"2020","unstructured":"Stapornwongkul, K. S., de Gennes, M., Cocconi, L., Salbreux, G. & Vincent, J. P. Patterning and growth control in vivo by an engineered GFP gradient. Science 370, 321\u2013327 (2020).","journal-title":"Science"},{"key":"1067_CR151","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1073\/pnas.0710487105","volume":"105","author":"G Barnea","year":"2008","unstructured":"Barnea, G. et al. The genetic design of signaling cascades to record receptor activation. Proc. Natl Acad. Sci. USA 105, 64\u201369 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1067_CR152","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s41589-018-0046-z","volume":"14","author":"L Scheller","year":"2018","unstructured":"Scheller, L., Strittmatter, T., Fuchs, D., Bojar, D. & Fussenegger, M. Generalized extracellular molecule sensor platform for programming cellular behavior. Nat. Chem. Biol. 14, 723\u2013729 (2018).","journal-title":"Nat. Chem. Biol."},{"key":"1067_CR153","doi-asserted-by":"publisher","first-page":"eaat6982","DOI":"10.1126\/science.aat6982","volume":"364","author":"HK Chung","year":"2019","unstructured":"Chung, H. K. et al. A compact synthetic pathway rewires cancer signaling to therapeutic effector release. Science 364, eaat6982 (2019).","journal-title":"Science"},{"key":"1067_CR154","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1126\/science.aat5062","volume":"361","author":"XJ Gao","year":"2018","unstructured":"Gao, X. J., Chong, L. S., Kim, M. S. & Elowitz, M. B. Programmable protein circuits in living cells. Science 361, 1252\u20131258 (2018).","journal-title":"Science"},{"key":"1067_CR155","doi-asserted-by":"publisher","first-page":"179ps177","DOI":"10.1126\/scitranslmed.3005568","volume":"5","author":"MA Fischbach","year":"2013","unstructured":"Fischbach, M. A., Bluestone, J. A. & Lim, W. A. Cell-based therapeutics: the next pillar of medicine. Sci. Transl. Med. 5, 179ps177 (2013).","journal-title":"Sci. Transl. Med."},{"key":"1067_CR156","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.cobme.2020.100252","volume":"16","author":"JC Lee","year":"2020","unstructured":"Lee, J. C., Walton, B. L., Hamann, C. A. & Brunger, J. M. Synthetic regulation of multicellular systems for regenerative engineering. Curr. Opin. Biomed. Eng. 16, 42\u201351 (2020).","journal-title":"Curr. Opin. Biomed. Eng."},{"key":"1067_CR157","doi-asserted-by":"publisher","first-page":"318ra201","DOI":"10.1126\/scitranslmed.aac4964","volume":"7","author":"L Schukur","year":"2015","unstructured":"Schukur, L., Geering, B., Charpin-El Hamri, G. & Fussenegger, M. Implantable synthetic cytokine converter cells with AND-gate logic treat experimental psoriasis. Sci. Transl. Med. 7, 318ra201 (2015).","journal-title":"Sci. Transl. Med."},{"key":"1067_CR158","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ymthe.2016.10.005","volume":"25","author":"A Smole","year":"2017","unstructured":"Smole, A., Lain\u0161\u010dek, D., Bezeljak, U., Horvat, S. & Jerala, R. A synthetic mammalian therapeutic gene circuit for sensing and suppressing inflammation. Mol. Ther. 25, 102\u2013119 (2017).","journal-title":"Mol. Ther."},{"key":"1067_CR159","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14397-8","volume":"11","author":"K Krawczyk","year":"2020","unstructured":"Krawczyk, K., Scheller, L., Kim, H. & Fussenegger, M. Rewiring of endogenous signaling pathways to genomic targets for therapeutic cell reprogramming. Nat. Commun. 11, 608 (2020).","journal-title":"Nat. Commun."},{"key":"1067_CR160","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1172\/JCI0214536","volume":"109","author":"AV Miagkov","year":"2002","unstructured":"Miagkov, A. V., Varley, A. W., Munford, R. S. & Makarov, S. S. Endogenous regulation of a therapeutic transgene restores homeostasis in arthritic joints. J. Clin. Invest. 109, 1223\u20131229 (2002).","journal-title":"J. Clin. Invest."},{"key":"1067_CR161","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1089\/ten.tea.2019.0027","volume":"25","author":"L Pferdehirt","year":"2019","unstructured":"Pferdehirt, L., Ross, A. K., Brunger, J. M. & Guilak, F. A synthetic gene circuit for self-regulating delivery of biologic drugs in engineered tissues. Tissue Eng. Part. A 25, 809\u2013820 (2019).","journal-title":"Tissue Eng. Part. A"},{"key":"1067_CR162","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3021","volume":"20","author":"S Gabner","year":"2018","unstructured":"Gabner, S. et al. Cytokine-induced interleukin-1 receptor antagonist protein expression in genetically engineered equine mesenchymal stem cells for osteoarthritis treatment. J. Gene Med. 20, e3021 (2018).","journal-title":"J. Gene Med."},{"key":"1067_CR163","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1002\/art.23598","volume":"58","author":"PS Rachakonda","year":"2008","unstructured":"Rachakonda, P. S., Rai, M. F. & Schmidt, M. F. Application of inflammation-responsive promoter for an in vitro arthritis model. Arthritis Rheum. 58, 2088\u20132097 (2008).","journal-title":"Arthritis Rheum."},{"key":"1067_CR164","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/sj.gt.3302182","volume":"11","author":"FA van de Loo","year":"2004","unstructured":"van de Loo, F. A. et al. An inflammation-inducible adenoviral expression system for local treatment of the arthritic joint. Gene Ther. 11, 581\u2013590 (2004).","journal-title":"Gene Ther."},{"key":"1067_CR165","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.stemcr.2017.03.022","volume":"8","author":"JM Brunger","year":"2017","unstructured":"Brunger, J. M., Zutshi, A., Willard, V. P., Gersbach, C. A. & Guilak, F. Genome engineering of stem cells for autonomously regulated, closed-loop delivery of biologic drugs. Stem Cell Rep. 8, 1202\u20131213 (2017).","journal-title":"Stem Cell Rep."},{"key":"1067_CR166","doi-asserted-by":"publisher","first-page":"eabj1414","DOI":"10.1126\/sciadv.abj1414","volume":"7","author":"YR Choi","year":"2021","unstructured":"Choi, Y. R. et al. A genome-engineered bioartificial implant for autoregulated anticytokine drug delivery. Sci. Adv. 7, eabj1414 (2021).","journal-title":"Sci. Adv."},{"key":"1067_CR167","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3390\/gels9020169","volume":"9","author":"KH Collins","year":"2023","unstructured":"Collins, K. H. et al. Hydrogel encapsulation of genome-engineered stem cells for long-term self-regulating anti-cytokine therapy. Gels 9, 169 (2023).","journal-title":"Gels"},{"key":"1067_CR168","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1089\/ten.tea.2016.0441","volume":"23","author":"N Farhang","year":"2017","unstructured":"Farhang, N. et al. CRISPR-based epigenome editing of cytokine receptors for the promotion of cell survival and tissue deposition in inflammatory environments. Tissue Eng. Part. A 23, 738\u2013749 (2017).","journal-title":"Tissue Eng. Part. A"},{"key":"1067_CR169","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1089\/hum.2019.005","volume":"30","author":"N Farhang","year":"2019","unstructured":"Farhang, N. et al. Lentiviral CRISPR epigenome editing of inflammatory receptors as a gene therapy strategy for disc degeneration. Hum. Gene Ther. 30, 1161\u20131175 (2019).","journal-title":"Hum. Gene Ther."},{"key":"1067_CR170","doi-asserted-by":"publisher","first-page":"4509","DOI":"10.1073\/pnas.91.10.4509","volume":"91","author":"JF Margolin","year":"1994","unstructured":"Margolin, J. F. et al. Kr\u00fcppel-associated boxes are potent transcriptional repression domains. Proc. Natl Acad. Sci. USA 91, 4509\u20134513 (1994).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1067_CR171","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.cell.2013.06.044","volume":"154","author":"LA Gilbert","year":"2013","unstructured":"Gilbert, L. A. et al. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell 154, 442\u2013451 (2013).","journal-title":"Cell"},{"key":"1067_CR172","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.cell.2013.02.022","volume":"152","author":"LS Qi","year":"2013","unstructured":"Qi, L. S. et al. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell 152, 1173\u20131183 (2013).","journal-title":"Cell"},{"key":"1067_CR173","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1016\/j.cell.2021.03.025","volume":"184","author":"JK Nu\u00f1ez","year":"2021","unstructured":"Nu\u00f1ez, J. K. et al. Genome-wide programmable transcriptional memory by CRISPR-based epigenome editing. Cell 184, 2503\u20132519.e2517 (2021).","journal-title":"Cell"},{"key":"1067_CR174","doi-asserted-by":"publisher","first-page":"eabd9858","DOI":"10.1126\/sciadv.abd9858","volume":"7","author":"RJ Nims","year":"2021","unstructured":"Nims, R. J. et al. A synthetic mechanogenetic gene circuit for autonomous drug delivery in engineered tissues. Sci. Adv. 7, eabd9858 (2021).","journal-title":"Sci. Adv."},{"key":"1067_CR175","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1056\/NEJMra1706169","volume":"379","author":"CH June","year":"2018","unstructured":"June, C. H. & Sadelain, M. Chimeric antigen receptor therapy. N. Engl. J. Med. 379, 64\u201373 (2018).","journal-title":"N. Engl. J. Med."},{"key":"1067_CR176","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1038\/mt.2009.83","volume":"17","author":"MC Milone","year":"2009","unstructured":"Milone, M. C. et al. Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo. Mol. Ther. 17, 1453\u20131464 (2009).","journal-title":"Mol. Ther."},{"key":"1067_CR177","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1158\/2159-8290.CD-12-0548","volume":"3","author":"M Sadelain","year":"2013","unstructured":"Sadelain, M., Brentjens, R. & Rivi\u00e8re, I. The basic principles of chimeric antigen receptor design. Cancer Discov. 3, 388\u2013398 (2013).","journal-title":"Cancer Discov."},{"key":"1067_CR178","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/sj.leu.2403302","volume":"18","author":"C Imai","year":"2004","unstructured":"Imai, C. et al. Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia. Leukemia 18, 676\u2013684 (2004).","journal-title":"Leukemia"},{"key":"1067_CR179","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41586-020-2403-9","volume":"583","author":"C Amor","year":"2020","unstructured":"Amor, C. et al. Senolytic CAR T cells reverse senescence-associated pathologies. Nature 583, 127\u2013132 (2020).","journal-title":"Nature"},{"key":"1067_CR180","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41413-022-00243-8","volume":"11","author":"A Fan","year":"2023","unstructured":"Fan, A. et al. Inhibition of fibroblast activation protein ameliorates cartilage matrix degradation and osteoarthritis progression. Bone Res. 11, 3 (2023).","journal-title":"Bone Res."},{"key":"1067_CR181","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1136\/ard-2022-223227","volume":"82","author":"H Swahn","year":"2023","unstructured":"Swahn, H. et al. Senescent cell population with ZEB1 transcription factor as its main regulator promotes osteoarthritis in cartilage and meniscus. Ann. Rheum. Dis. 82, 403\u2013415 (2023).","journal-title":"Ann. Rheum. Dis."},{"key":"1067_CR182","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41586-019-1546-z","volume":"573","author":"H Aghajanian","year":"2019","unstructured":"Aghajanian, H. et al. Targeting cardiac fibrosis with engineered T cells. Nature 573, 430\u2013433 (2019).","journal-title":"Nature"},{"key":"1067_CR183","doi-asserted-by":"publisher","first-page":"5382","DOI":"10.4049\/jimmunol.1300024","volume":"190","author":"Z Qian","year":"2013","unstructured":"Qian, Z. et al. Engineered regulatory T cells coexpressing MHC class II: peptide complexes are efficient inhibitors of autoimmune T cell function and prevent the development of autoimmune arthritis. J. Immunol. 190, 5382\u20135391 (2013).","journal-title":"J. Immunol."},{"key":"1067_CR184","doi-asserted-by":"publisher","first-page":"16","DOI":"10.4049\/jimmunol.2100643","volume":"208","author":"KB Whittington","year":"2022","unstructured":"Whittington, K. B. et al. CD8+ T cells expressing an HLA-DR1 chimeric antigen receptor target autoimmune CD4+ T cells in an antigen-specific manner and inhibit the development of autoimmune arthritis. J. Immunol. 208, 16\u201326 (2022).","journal-title":"J. Immunol."},{"key":"1067_CR185","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature21405","volume":"543","author":"J Eyquem","year":"2017","unstructured":"Eyquem, J. et al. Targeting a CAR to the TRAC locus with CRISPR\/Cas9 enhances tumour rejection. Nature 543, 113\u2013117 (2017).","journal-title":"Nature"},{"key":"1067_CR186","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.cell.2020.03.039","volume":"181","author":"TL Roth","year":"2020","unstructured":"Roth, T. L. et al. Pooled knockin targeting for genome engineering of cellular immunotherapies. Cell 181, 728\u2013744.e721 (2020).","journal-title":"Cell"},{"key":"1067_CR187","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41586-018-0326-5","volume":"559","author":"TL Roth","year":"2018","unstructured":"Roth, T. L. et al. Reprogramming human T cell function and specificity with non-viral genome targeting. Nature 559, 405\u2013409 (2018).","journal-title":"Nature"},{"key":"1067_CR188","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1126\/science.aaf9739","volume":"355","author":"VC Luca","year":"2017","unstructured":"Luca, V. C. et al. Notch-Jagged complex structure implicates a catch bond in tuning ligand sensitivity. Science 355, 1320\u20131324 (2017).","journal-title":"Science"},{"key":"1067_CR189","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.devcel.2015.05.004","volume":"33","author":"WR Gordon","year":"2015","unstructured":"Gordon, W. R. et al. Mechanical allostery: evidence for a force requirement in the proteolytic activation of notch. Dev. Cell 33, 729\u2013736 (2015).","journal-title":"Dev. Cell"},{"key":"1067_CR190","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.cell.2016.01.012","volume":"164","author":"L Morsut","year":"2016","unstructured":"Morsut, L. et al. Engineering customized cell sensing and response behaviors using synthetic notch receptors. Cell 164, 780\u2013791 (2016).","journal-title":"Cell"},{"key":"1067_CR191","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1016\/j.cell.2022.03.023","volume":"185","author":"I Zhu","year":"2022","unstructured":"Zhu, I. et al. Modular design of synthetic receptors for programmed gene regulation in cell therapies. Cell 185, 1431\u20131443.e1416 (2022).","journal-title":"Cell"},{"key":"1067_CR192","doi-asserted-by":"publisher","first-page":"156","DOI":"10.2174\/1566523216666160524144041","volume":"16","author":"TA Das","year":"2016","unstructured":"Das, T. A., Tenenbaum, L. & Berkhout, B. Tet-on systems for doxycycline-inducible gene expression. Curr. Gene Ther. 16, 156\u2013167 (2016).","journal-title":"Curr. Gene Ther."},{"key":"1067_CR193","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.cell.2016.01.011","volume":"164","author":"KT Roybal","year":"2016","unstructured":"Roybal, K. T. et al. Precision tumor recognition by T cells with combinatorial antigen-sensing circuits. Cell 164, 770\u2013779 (2016).","journal-title":"Cell"},{"key":"1067_CR194","doi-asserted-by":"publisher","first-page":"eabe7378","DOI":"10.1126\/scitranslmed.abe7378","volume":"13","author":"JH Choe","year":"2021","unstructured":"Choe, J. H. et al. SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastoma. Sci. Transl. Med. 13, eabe7378 (2021).","journal-title":"Sci. Transl. Med."},{"key":"1067_CR195","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37863-5","volume":"14","author":"E Ruffo","year":"2023","unstructured":"Ruffo, E. et al. Post-translational covalent assembly of CAR and synNotch receptors for programmable antigen targeting. Nat. Commun. 14, 2463 (2023).","journal-title":"Nat. Commun."},{"key":"1067_CR196","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1126\/science.aat0271","volume":"361","author":"S Toda","year":"2018","unstructured":"Toda, S., Blauch, L. R., Tang, S. K. Y., Morsut, L. & Lim, W. A. Programming self-organizing multicellular structures with synthetic cell-cell signaling. Science 361, 156\u2013162 (2018).","journal-title":"Science"},{"key":"1067_CR197","doi-asserted-by":"publisher","first-page":"122099","DOI":"10.1016\/j.biomaterials.2023.122099","volume":"297","author":"JC Lee","year":"2023","unstructured":"Lee, J. C. et al. Instructional materials that control cellular activity through synthetic Notch receptors. Biomaterials 297, 122099 (2023).","journal-title":"Biomaterials"},{"key":"1067_CR198","doi-asserted-by":"publisher","first-page":"eabo5503","DOI":"10.1126\/science.abo5503","volume":"378","author":"S Zhang","year":"2022","unstructured":"Zhang, S. et al. Monitoring of cell-cell communication and contact history in mammals. Science 378, eabo5503 (2022).","journal-title":"Science"},{"key":"1067_CR199","doi-asserted-by":"publisher","first-page":"dev200226","DOI":"10.1242\/dev.200226","volume":"149","author":"M Malaguti","year":"2022","unstructured":"Malaguti, M. et al. SyNPL: synthetic notch pluripotent cell lines to monitor and manipulate cell interactions in vitro and in vivo. Development 149, dev200226 (2022).","journal-title":"Development"},{"key":"1067_CR200","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1136\/ard-2022-222773","volume":"82","author":"AJ Knights","year":"2023","unstructured":"Knights, A. J. et al. Synovial fibroblasts assume distinct functional identities and secrete R-spondin 2 in osteoarthritis. Ann. Rheum. Dis. 82, 272\u2013282 (2023).","journal-title":"Ann. Rheum. Dis."},{"key":"1067_CR201","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11926-022-01093-3","volume":"25","author":"PX Bradley","year":"2023","unstructured":"Bradley, P. X. et al. The interplay of biomechanical and biological changes following meniscus injury. Curr. Rheumatol. Rep. 25, 35\u201346 (2023).","journal-title":"Curr. Rheumatol. Rep."},{"key":"1067_CR202","doi-asserted-by":"publisher","first-page":"6016","DOI":"10.3390\/ijms21176016","volume":"21","author":"E Belluzzi","year":"2020","unstructured":"Belluzzi, E. et al. Infrapatellar fat pad gene expression and protein production in patients with and without osteoarthritis. Int. J. Mol. Sci. 21, 6016 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"1067_CR203","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2021096118","volume":"118","author":"KH Collins","year":"2021","unstructured":"Collins, K. H. et al. Adipose tissue is a critical regulator of osteoarthritis. Proc. Natl Acad. Sci. USA 118, e2021096118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1067_CR204","doi-asserted-by":"publisher","first-page":"607764","DOI":"10.3389\/fcell.2020.607764","volume":"8","author":"X Zhu","year":"2020","unstructured":"Zhu, X., Chan, Y. T., Yung, P. S. H., Tuan, R. S. & Jiang, Y. Subchondral bone remodeling: a therapeutic target for osteoarthritis. Front. Cell Dev. Biol. 8, 607764 (2020).","journal-title":"Front. Cell Dev. Biol."},{"key":"1067_CR205","doi-asserted-by":"publisher","DOI":"10.1002\/alz.082650","volume":"19","author":"S Cohen","year":"2023","unstructured":"Cohen, S. et al. Interim phase 1 part A results for ALN-APP, the first investigational RNAi therapeutic in development for Alzheimer\u2019s disease. Alzheimers Dementia 19, e082650 (2023).","journal-title":"Alzheimers Dementia"},{"key":"1067_CR206","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1016\/j.clinthera.2006.10.006","volume":"28","author":"A Kivitz","year":"2006","unstructured":"Kivitz, A. et al. Clinical assessment of pain, tolerability, and preference of an autoinjection pen versus a prefilled syringe for patient self-administration of the fully human, monoclonal antibody adalimumab: the TOUCH trial. Clin. Therapeutics 28, 1619\u20131629 (2006).","journal-title":"Clin. Therapeutics"},{"key":"1067_CR207","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1093\/rheumatology\/kem091","volume":"46","author":"S Bombardieri","year":"2007","unstructured":"Bombardieri, S. et al. Effectiveness of adalimumab for rheumatoid arthritis in patients with a history of TNF-antagonist therapy in clinical practice. Rheumatology 46, 1191\u20131199 (2007).","journal-title":"Rheumatology"},{"key":"1067_CR208","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nature17946","volume":"533","author":"AC Komor","year":"2016","unstructured":"Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A. & Liu, D. R. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533, 420\u2013424 (2016).","journal-title":"Nature"},{"key":"1067_CR209","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nature24644","volume":"551","author":"NM Gaudelli","year":"2017","unstructured":"Gaudelli, N. M. et al. Programmable base editing of A\u2022T to G\u2022C in genomic DNA without DNA cleavage. Nature 551, 464\u2013471 (2017).","journal-title":"Nature"},{"key":"1067_CR210","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/s41573-020-0084-6","volume":"19","author":"EM Porto","year":"2020","unstructured":"Porto, E. M., Komor, A. C., Slaymaker, I. M. & Yeo, G. W. Base editing: advances and therapeutic opportunities. Nat. Rev. Drug. Discov. 19, 839\u2013859 (2020).","journal-title":"Nat. Rev. Drug. Discov."},{"key":"1067_CR211","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","volume":"576","author":"AV Anzalone","year":"2019","unstructured":"Anzalone, A. V. et al. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature 576, 149\u2013157 (2019).","journal-title":"Nature"},{"key":"1067_CR212","doi-asserted-by":"publisher","first-page":"5635","DOI":"10.1016\/j.cell.2021.09.018","volume":"184","author":"PJ Chen","year":"2021","unstructured":"Chen, P. J. et al. Enhanced prime editing systems by manipulating cellular determinants of editing outcomes. Cell 184, 5635\u20135652.e5629 (2021).","journal-title":"Cell"},{"key":"1067_CR213","doi-asserted-by":"publisher","first-page":"1039315","DOI":"10.3389\/fbioe.2023.1039315","volume":"11","author":"Z Huang","year":"2023","unstructured":"Huang, Z. & Liu, G. Current advancement in the application of prime editing. Front. Bioeng. Biotechnol. 11, 1039315 (2023).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"1067_CR214","first-page":"478","volume":"7","author":"B Wang","year":"2022","unstructured":"Wang, B. et al. A low dose cell therapy system for treating osteoarthritis: in vivo study and in vitro mechanistic investigations. Bioact. Mater. 7, 478\u2013490 (2022).","journal-title":"Bioact. Mater."},{"key":"1067_CR215","doi-asserted-by":"publisher","first-page":"eaax3063","DOI":"10.1126\/scitranslmed.aax3063","volume":"12","author":"A-S Thorup","year":"2020","unstructured":"Thorup, A.-S. et al. ROR2 blockade as a therapy for osteoarthritis. Sci. Transl. Med. 12, eaax3063 (2020).","journal-title":"Sci. Transl. Med."},{"key":"1067_CR216","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1016\/j.joca.2021.05.025","volume":"29","author":"A Kucharski","year":"2021","unstructured":"Kucharski, A. et al. 4-Aminobutyrate aminotransferase regulates chondrocyte homeostasis and can be targeted using peptide-siRNA nanoparticles to attenuate osteoarthritis in a murine injury model. Osteoarthritis Cartilage 29, S13\u2013S14 (2021).","journal-title":"Osteoarthritis Cartilage"},{"key":"1067_CR217","doi-asserted-by":"publisher","first-page":"617","DOI":"10.2147\/IJN.S142797","volume":"13","author":"S Wang","year":"2018","unstructured":"Wang, S. et al. A novel therapeutic strategy for cartilage diseases based on lipid nanoparticle-RNAi delivery system. Int. J. Nanomed. 13, 617\u2013631 (2018).","journal-title":"Int. J. Nanomed."},{"key":"1067_CR218","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3390\/polym12020443","volume":"12","author":"HJ Shin","year":"2020","unstructured":"Shin, H. J. et al. p47phox siRNA-Loaded PLGA nanoparticles suppress ROS\/oxidative stress-induced chondrocyte damage in osteoarthritis. Polymers 12, 443 (2020).","journal-title":"Polymers"},{"key":"1067_CR219","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1039\/D1BM01941D","volume":"10","author":"H Park","year":"2022","unstructured":"Park, H. et al. p16INK4a-siRNA nanoparticles attenuate cartilage degeneration in osteoarthritis by inhibiting inflammation in fibroblast-like synoviocytes. Biomater. Sci. 10, 3223\u20133235 (2022).","journal-title":"Biomater. Sci."},{"key":"1067_CR220","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.joca.2023.02.040","volume":"31","author":"A Kucharski","year":"2023","unstructured":"Kucharski, A. et al. Nanoparticle based dnmt3b gene therapy attenuates arthritis progression in a murine injury model. Osteoarthritis Cartilage 31, 695\u2013696 (2023).","journal-title":"Osteoarthritis Cartilage"},{"key":"1067_CR221","doi-asserted-by":"publisher","first-page":"eadf0988","DOI":"10.1126\/sciadv.adf0988","volume":"9","author":"H Chen","year":"2023","unstructured":"Chen, H. et al. Urchin-like ceria nanoparticles for enhanced gene therapy of osteoarthritis. Sci. Adv. 9, eadf0988 (2023).","journal-title":"Sci. Adv."},{"key":"1067_CR222","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1136\/annrheumdis-2018-214724","volume":"78","author":"L Zhao","year":"2019","unstructured":"Zhao, L. et al. Exploration of CRISPR\/Cas9-based gene editing as therapy for osteoarthritis. Ann. Rheum. Dis. 78, 676\u2013682 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"1067_CR223","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.omtn.2022.03.024","volume":"28","author":"Y Fan","year":"2022","unstructured":"Fan, Y., Zhao, L., Lai, Y., Lu, K. & Huang, J. CRISPR-Cas9-mediated loss of function of beta-catenin attenuates intervertebral disc degeneration. Mol. Ther. Nucleic Acids 28, 387\u2013396 (2022).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"1067_CR224","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/nmeth.2600","volume":"10","author":"P Perez-Pinera","year":"2013","unstructured":"Perez-Pinera, P. et al. RNA-guided gene activation by CRISPR-Cas9-based transcription factors. Nat. Methods 10, 973\u2013976 (2013).","journal-title":"Nat. Methods"},{"key":"1067_CR225","doi-asserted-by":"publisher","first-page":"5921","DOI":"10.1016\/j.biomaterials.2014.03.073","volume":"35","author":"KA Glass","year":"2014","unstructured":"Glass, K. A. et al. Tissue-engineered cartilage with inducible and tunable immunomodulatory properties. Biomaterials 35, 5921\u20135931 (2014).","journal-title":"Biomaterials"},{"key":"1067_CR226","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nchembio.2253","volume":"13","author":"KA Schwarz","year":"2017","unstructured":"Schwarz, K. A., Daringer, N. M., Dolberg, T. B. & Leonard, J. N. Rewiring human cellular input-output using modular extracellular sensors. Nat. Chem. Biol. 13, 202\u2013209 (2017).","journal-title":"Nat. Chem. Biol."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41584-023-01067-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-023-01067-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-023-01067-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T09:04:07Z","timestamp":1706605447000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41584-023-01067-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,22]]},"references-count":226,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["1067"],"URL":"https:\/\/doi.org\/10.1038\/s41584-023-01067-4","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,22]]},"assertion":[{"value":"7 December 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.L.D., C.R.D., and R.D. hold patents related to drug delivery (US20170096517A1 (C.L.D.); WO2018213361A1 (C.L.D.); WO2019068098A1 (C.L.D., C.R.D.); US20180064749A1 (C.L.D.); WO2023059833A1 (C.L.D. and R.D.); WO2023034561A2 (C.L.D.); US2023\/018982 (C.L.D., C.R.D. and R.D.; filed)). J.M.B., B.L.W., and C.L.D. hold patents related to cell engineering (US-11319555-B2 (J.M.B.); US-10954513-B2 (J.M.B.); US-20230295262-A1 (J.M.B., B.L.W. and C.L.D.; filed)). These patents reflect long-standing interest and innovation in the fields of RNA delivery and cell design.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}